The role of dendritic cells in Mycobacterium tuberculosis infection

Virulence

Volumn 3, Issue 7, 2012, Pages

  Mihret, Adane ^a,b  

^a ARMAUER HANSEN RESEARCH INSTITUTE   (Ethiopia)

^b ADDIS ABABA UNIVERSITY   (Ethiopia)

Author keywords

Activation; Dendritic cells; M. tuberculosis; Maturation; T cells

Indexed keywords

B7 ANTIGEN; CD209 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CD86 ANTIGEN; DECTIN 1; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 8; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MANNOSE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9;

ADAPTIVE IMMUNITY; ANTIGEN DETECTION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CRYPTOCOCCUS NEOFORMANS; CYTOKINE PRODUCTION; DENDRITIC CELL; ENDOSOME; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOCOMPROMISED PATIENT; INNATE IMMUNITY; NONHUMAN; PHAGOCYTOSIS; PLASMACYTOID DENDRITIC CELL; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; TH1 CELL; TH17 CELL; TH2 CELL; IMMUNE EVASION; IMMUNOLOGY; MICROBIOLOGY; MYCOBACTERIUM TUBERCULOSIS; PATHOGENICITY; PATHOLOGY; TUBERCULOSIS;

CD4-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; HUMANS; IMMUNE EVASION; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

EID: 84870927723     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: 10.4161/viru.22586     Document Type: Review

References (95)

1. WHO. Global tuberculosis control. WHO report 2011. Geneva, World Health Organization 2011.
2. Schluger NW, Rom WN. The host immune response to tuberculosis. Am J Respir Crit Care Med 1998; 157: 679-91; PMID:9517576
3. Henderson RA, Watkins SC, Flynn JL. Activation of human dendritic cells following infection with Mycobacterium tuberculosis. J Immunol 1997; 159: 635-43; PMID:9218578
4. Thurnher M, Ramoner R, Gastl G, Radmayr C, Böck G, Herold M, et al. Bacillus Calmette-Guérin mycobacteria stimulate human blood dendritic cells. Int J Cancer 1997; 70:128-34; PMID:8985101; http://dx.doi.org/10.1002/(SICI)1097-0215(19970106)70:1,128::AID-IJC19.3.0.CO;2-H
5. Ernst JD. Macrophage receptors for Mycobacterium tuberculosis. Infect Immun 1998; 66:1277-81; PMID: 9529042
6. Aderem A, Underhill DM. Mechanisms of phagocytosis in macrophages. Annu Rev Immunol 1999; 17:593-623; PMID:10358769; http://dx.doi.org/10.1146/annurev.immunol.17.1.593
7. Hirsch CS, Ellner JJ, Russell DG, Rich EA. Complement receptor-mediated uptake and tumor necrosis factor-alpha-mediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages. J Immunol 1994; 152:743-53; PMID:8283049
8. Kleinnijenhuis J, Oosting M, Joosten LA, Netea MG, Van Crevel R. Innate immune recognition of Mycobacterium tuberculosis. Clin Dev Immunol 2011; 2011:405310; PMID:21603213; http://dx.doi. org/10.1155/2011/405310
9. van Crevel R, Ottenhoff TH, van der Meer JW. Innate immunity to Mycobacterium tuberculosis. Adv Exp Med Biol 2003; 531:241-7; PMID:12916796; http://dx.doi.org/10.1007/978-1-4615-0059-9_20
10. van Crevel R, Ottenhoff TH, van der Meer JW. Innate immunity to Mycobacterium tuberculosis. Clin Microbiol Rev 2002; 15:294-309; PMID:11932234; http://dx.doi.org/10.1128/CMR.15.2.294-309.2002
11. Flynn JL, Chan J. Immunology of tuberculosis. Annu Rev Immunol 2001; 19:93-129; PMID:11244032; http://dx.doi.org/10.1146/annurev.immunol.19.1.93
12. Giacomini E, Iona E, Ferroni L, Miettinen M, Fattorini L, Orefici G, et al. Infection of human macrophages and dendritic cells with Mycobacterium tuberculosis induces a differential cytokine gene expression that modulates T cell response. J Immunol 2001; 166:7033-41; PMID:11390447
13. Desjardins M, Huber LA, Parton RG, Griffiths G. Biogenesis of phagolysosomes proceeds through a sequential series of interactions with the endocytic apparatus. J Cell Biol 1994; 124:677-88; PMID: 8120091; http://dx.doi.org/10.1083/jcb.124.5.677
14. Desjardins M. Biogenesis of phagolysosomes: the 'kiss and run' hypothesis. Trends Cell Biol 1995; 5:183-6; PMID:14731444; http://dx.doi.org/10.1016/S0962-8924(00)88989-8
15. Gonzalez-Juarrero M, Shim TS, Kipnis A, Junqueira-Kipnis AP, Orme IM. Dynamics of macrophage cell populations during murine pulmonary tuberculosis. J Immunol 2003; 171:3128-35; PMID:12960339
16. Flynn JL. Mutual attraction: does it benefit the host or the bug? Nat Immunol 2004; 5:778-9; PMID: 15282559; http://dx.doi.org/10.1038/ni0804-778
17. Marino S, Pawar S, Fuller CL, Reinhart TA, Flynn JL, Kirschner DE. Dendritic cell trafficking and antigen presentation in the human immune response to Mycobacterium tuberculosis. J Immunol 2004; 173: 494-506; PMID:15210810
18. Boom WH, Canaday DH, Fulton SA, Gehring AJ, Rojas RE, Torres M. Human immunity to M. tuberculosis: T cell subsets and antigen processing. Tuberculosis (Edinb) 2003; 83:98-106; PMID: 12758197; http://dx.doi.org/10.1016/S1472-9792(02) 00054-9
19. Kaufmann SH, Cole ST, Mizrahi V, Rubin E, Nathan C. Mycobacterium tuberculosis and the host response. J Exp Med 2005; 201:1693-7; PMID:15939785; http://dx.doi.org/10.1084/jem.20050842
20. Müller I, Cobbold SP, Waldmann H, Kaufmann SH. Impaired resistance to Mycobacterium tuberculosis infection after selective in vivo depletion of L3T4+ and Lyt-2+ T cells. Infect Immun 1987; 55:2037-41; PMID:3114143
21. Orme IM, Collins FM. Adoptive protection of the Mycobacterium tuberculosis-infected lung. Dissociation between cells that passively transfer protective immunity and those that transfer delayed-type hypersensitivity to tuberculin. Cell Immunol 1984; 84:113-20; PMID: 6421492; http://dx.doi.org/10.1016/0008-8749(84) 90082-0
22. Orme IM, Collins FM. Protection against Mycobacterium tuberculosis infection by adoptive immunotherapy. Requirement for T cell-deficient recipients. J Exp Med 1983; 158:74-83; PMID: 6602861; http://dx.doi.org/10.1084/jem.158.1.74
23. Tascon RE, Stavropoulos E, Lukacs KV, Colston MJ. Protection against Mycobacterium tuberculosis infection by CD8+ T cells requires the production of gamma interferon. Infect Immun 1998; 66:830-4; PMID: 9453650
24. Caruso AM, Serbina N, Klein E, Triebold K, Bloom BR, Flynn JL. Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis. J Immunol 1999; 162:5407-16; PMID:10228018
25. Selwyn PAHD, Hartel D, Lewis VA, Schoenbaum EE, Vermund SH, Klein RS, et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989; 320:545-50; PMID:2915665; http://dx. doi.org/10.1056/NEJM198903023200901
26. Andreasen SO, Christensen JE, Marker O, Thomsen AR. Role of CD40 ligand and CD28 in induction and maintenance of antiviral CD8+ effector T cell responses. J Immunol 2000; 164:3689-97; PMID: 10725727
27. Oddo M, Renno T, Attinger A, Bakker T, MacDonald HR, Meylan PR. Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis. J Immunol 1998; 160:5448-54; PMID:9605147
28. Keane J, Balcewicz-Sablinska MK, Remold HG, Chupp GL, Meek BB, Fenton MJ, et al. Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis. Infect Immun 1997; 65:298-304; PMID:8975927
29. Scanga CA, Mohan VP, Yu K, Joseph H, Tanaka K, Chan J, et al. Depletion of CD4(+) T cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon gamma and nitric oxide synthase 2. J Exp Med 2000; 192:347-58; PMID:10934223; http://dx.doi.org/10.1084/jem.192.3.347
30. Kaufmann SH. Envisioning future strategies for vaccination against tuberculosis. Nat Rev Immunol 2006; 6:699-704; PMID:16917508; http://dx.doi.org/10.1038/nri1920
31. Cooper AM. Cell-mediated immune responses in tuberculosis. Annu Rev Immunol 2009; 27:393-422; PMID:19302046; http://dx.doi.org/10.1146/annurev. immunol.021908.132703
32. van der Wel N, Hava D, Houben D, Fluitsma D, van Zon M, Pierson J, et al. M. tuberculosis and M. leprae translocate from the phagolysosome to the cytosol in myeloid cells. Cell 2007; 129:1287-98; PMID: 17604718; http://dx.doi.org/10.1016/j.cell.2007.05. 059
33. Winau F, Weber S, Sad S, de Diego J, Hoops SL, Breiden B, et al. Apoptotic vesicles crossprime CD8 T cells and protect against tuberculosis. Immunity 2006; 24:105-17; PMID:16413927; http://dx.doi.org/10. 1016/j.immuni.2005.12.001
34. Stenger S, Mazzaccaro RJ, Uyemura K, Cho S, Barnes PF, Rosat JP, et al. Differential effects of cytolytic T cell subsets on intracellular infection. Science 1997; 276: 1684-7; PMID:9180075; http://dx.doi.org/10.1126/science.276.5319.1684
35. Lewinsohn DM, Alderson MR, Briden AL, Riddell SR, Reed SG, Grabstein KH. Characterization of human CD8+ T cells reactive with Mycobacterium tuberculosis-infected antigen-presenting cells. J Exp Med 1998; 187:1633-40; PMID:9584141; http://dx.doi. org/10.1084/jem.187.10.1633
36. Lewinsohn DM, Briden AL, Reed SG, Grabstein KH, Alderson MR. Mycobacterium tuberculosis-reactive CD8+ T lymphocytes: the relative contribution of classical versus nonclassical HLA restriction. J Immunol 2000; 165:925-30; PMID:10878367
37. Kaufmann SH. gamma/delta and other unconventional T lymphocytes: what do they see and what do they do? Proc Natl Acad Sci U S A 1996; 93:2272-9; PMID: 8637862; http://dx.doi.org/10.1073/pnas.93.6.2272
38. Porcelli SA, Modlin RL. The CD1 system: antigenpresenting molecules for T cell recognition of lipids and glycolipids. Annu Rev Immunol 1999; 17:297-329; PMID:10358761; http://dx.doi.org/10.1146/annurev. immunol.17.1.297
39. Ulrichs T, Porcelli SA. CD1 proteins: targets of T cell recognition in innate and adaptive immunity. Rev Immunogenet 2000; 2:416-32; PMID:11256748
40. D'Souza CD, Cooper AM, Frank AA, Mazzaccaro RJ, Bloom BR, Orme IM. An anti-inflammatory role for gamma delta T lymphocytes in acquired immunity to Mycobacterium tuberculosis. J Immunol 1997; 158: 1217-21; PMID:9013962
41. Ladel CH, Blum C, Dreher A, Reifenberg K, Kaufmann SH. Protective role of gamma/delta T cells and alpha/beta T cells in tuberculosis. Eur J Immunol 1995; 25:2877-81; PMID:7589086; http://dx.doi.org/10.1002/eji.1830251025
42. Behr-Perst SI, Munk ME, Schaberg T, Ulrichs T, Schulz RJ, Kaufmann SH. Phenotypically activated gammadelta T lymphocytes in the peripheral blood of patients with tuberculosis. J Infect Dis 1999; 180:141-9; PMID:10353872; http://dx.doi.org/10.1086/314844
43. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993; 178:2249-54; PMID:7504064; http://dx.doi.org/10.1084/jem.178.6.2249
44. Jouanguy E, Döffinger R, Dupuis S, Pallier A, Altare F, Casanova JL. IL-12 and IFN-gamma in host defense against mycobacteria and salmonella in mice and men. Curr Opin Immunol 1999; 11:346-51; PMID: 10375558; http://dx.doi.org/10.1016/S0952-7915(99) 80055-7
45. Flynn JL, Goldstein MM, Chan J, Triebold KJ, Pfeffer K, Lowenstein CJ, et al. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 1995; 2:561-72; PMID:7540941; http://dx.doi.org/10.1016/1074-7613(95)90001-2
46. Schaible UE, Collins HL, Kaufmann SH. Confrontation between intracellular bacteria and the immune system. Adv Immunol 1999; 71:267-377; PMID:9917916; http://dx.doi.org/10.1016/S0065-2776(08)60405-8
47. Dinarello CA. Anti-cytokine therapeutics and infections. Vaccine 2003; 21(Suppl 2):S24-34; PMID: 12763679; http://dx.doi.org/10.1016/S0264-410X (03)00196-8
48. Bean AG, Roach DR, Briscoe H, France MP, Korner H, Sedgwick JD, et al. Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin. J Immunol 1999; 162:3504-11; PMID:10092807
49. Vaday GG, Franitza S, Schor H, Hecht I, Brill A, Cahalon L, et al. Combinatorial signals by inflammatory cytokines and chemokines mediate leukocyte interactions with extracellular matrix. J Leukoc Biol 2001; 69:885-92; PMID:11404372
50. Keane J. TNF-blocking agents and tuberculosis: new drugs illuminate an old topic. Rheumatology (Oxford) 2005; 44:714-20; PMID:15741198; http://dx.doi.org/10.1093/rheumatology/keh567
51. Cooper AM, Magram J, Ferrante J, Orme IM. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis. J Exp Med 1997; 186:39-45; PMID:9206995; http://dx.doi.org/10. 1084/jem.186.1.39
52. Flynn JL, Goldstein MM, Triebold KJ, Sypek J, Wolf S, Bloom BR. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J Immunol 1995; 155:2515-24; PMID:7650381
53. Lowrie DB. DNA vaccines against tuberculosis. Curr Opin Mol Ther 1999; 1:30-3; PMID:11249680
54. Altare F, Durandy A, Lammas D, Emile JF, Lamhamedi S, Le Deist F, et al. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 1998; 280:1432-5; PMID:9603732; http://dx.doi.org/10.1126/science.280.5368.1432
55. Rhoades ER, Cooper AM, Orme IM. Chemokine response in mice infected with Mycobacterium tuberculosis. Infect Immun 1995; 63:3871-7; PMID: 7558294
56. Orme IM, Cooper AM. Cytokine/chemokine cascades in immunity to tuberculosis. Immunol Today 1999; 20:307-12; PMID:10379048; http://dx.doi.org/10. 1016/S0167-5699(98)01438-8
57. Juffermans NP, Paxton WA, Dekkers PE, Verbon A, de Jonge E, Speelman P, et al. Up-regulation of HIV coreceptors CXCR4 and CCR5 on CD4(+) T cells during human endotoxemia and after stimulation with (myco)bacterial antigens: the role of cytokines. Blood 2000; 96:2649-54; PMID:11023494
58. Steinman RM, Witmer-Pack M, Inaba K. Dendritic cells: antigen presentation, accessory function and clinical relevance. Adv Exp Med Biol 1993; 329:1-9; PMID:8379358; http://dx.doi.org/10.1007/978-1-4615-2930-9_1
59. Mellman I, Steinman RM. Dendritic cells: specialized and regulated antigen processing machines. Cell 2001; 106:255-8; PMID:11509172; http://dx.doi.org/10. 1016/S0092-8674(01)00449-4
60. Lipscomb MF, Masten BJ. Dendritic cells: immune regulators in health and disease. Physiol Rev 2002; 82: 97-130; PMID:11773610
61. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392:245-52; PMID:9521319; http://dx.doi.org/10.1038/32588
62. Sallusto F, Cella M, Danieli C, Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 1995; 182:389-400; PMID:7629501; http://dx.doi.org/10.1084/jem.182.2.389
63. Geijtenbeek TB, Krooshoop DJ, Bleijs DA, van Vliet SJ, van Duijnhoven GC, Grabovsky V, et al. DCSIGN-ICAM-2 interaction mediates dendritic cell trafficking. Nat Immunol 2000; 1:353-7; PMID: 11017109; http://dx.doi.org/10.1038/79815
64. Valladeau JRO, Ravel O, Dezutter-Dambuyant C, Moore K, Kleijmeer M, Liu Y, et al. Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity 2000; 12:71-81; PMID: 10661407; http://dx.doi.org/10.1016/S1074-7613(00) 80160-0
65. Rescigno M, Granucci F, Ricciardi-Castagnoli P. Molecular events of bacterial-induced maturation of dendritic cells. J Clin Immunol 2000; 20:161-6; PMID:10941823; http://dx.doi.org/10.1023/A: 1006629328178
66. Albert ML, Pearce SF, Francisco LM, Sauter B, Roy P, Silverstein RL, et al. Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J Exp Med 1998; 188:1359-68; PMID:9763615; http://dx.doi.org/10.1084/jem.188.7.1359
67. Visintin A, Mazzoni A, Spitzer JH, Wyllie DH, Dower SK, Segal DM. Regulation of Toll-like receptors in human monocytes and dendritic cells. J Immunol 2001; 166:249-55; PMID:11123299
68. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000; 18:767-811; PMID:10837075; http://dx.doi.org/10.1146/annurev.immunol.18.1.767
69. Reis e Sousa C, Hieny S, Scharton-Kersten T, Jankovic D, Charest H, Germain RN, et al. In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas. J Exp Med 1997; 186: 1819-29; PMID:9382881; http://dx.doi.org/10.1084/jem.186.11.1819
70. Förtsch D, Röllinghoff M, Stenger S. IL-10 converts human dendritic cells into macrophage-like cells with increased antibacterial activity against virulent Mycobacterium tuberculosis. J Immunol 2000; 165: 978-87; PMID:10878374
71. Tascon RE, Soares CS, Ragno S, Stavropoulos E, Hirst EM, Colston MJ. Mycobacterium tuberculosis-activated dendritic cells induce protective immunity in mice. Immunology 2000; 99:473-80; PMID: 10712679; http://dx.doi.org/10.1046/j.1365-2567. 2000.00963.x
72. Demangel C, Britton WJ. Interaction of dendritic cells with mycobacteria: where the action starts. Immunol Cell Biol 2000; 78:318-24; PMID:10947855; http://dx.doi.org/10.1046/j.1440-1711.2000.00935.x
73. Mohagheghpour N, van Vollenhoven A, Goodman J, Bermudez LE. Interaction of Mycobacterium avium with human monocyte-derived dendritic cells. Infect Immun 2000; 68:5824-9; PMID:10992491; http://dx. doi.org/10.1128/IAI.68.10.5824-5829.2000
74. Sertl K, Takemura T, Tschachler E, Ferrans VJ, Kaliner MA, Shevach EM. Dendritic cells with antigenpresenting capability reside in airway epithelium, lung parenchyma, and visceral pleura. J Exp Med 1986; 163: 436-51; PMID:3511172; http://dx.doi.org/10.1084/jem.163.2.436
75. Holt PG, Schon-Hegrad MA. Localization of T cells, macrophages and dendritic cells in rat respiratory tract tissue: implications for immune function studies. Immunology 1987; 62:349-56; PMID:3499375
76. van Haarst JM, Hoogsteden HC, de Wit HJ, Verhoeven GT, Havenith CE, Drexhage HA. Dendritic cells and their precursors isolated from human bronchoalveolar lavage: immunocytologic and functional properties. Am J Respir Cell Mol Biol 1994; 11:344-50; PMID:8086170
77. Kaufmann SH, Schaible UE. A dangerous liaison between two major killers: Mycobacterium tuberculosis and HIV target dendritic cells through DC-SIGN. J Exp Med 2003; 197:1-5; PMID:12515808; http://dx. doi.org/10.1084/jem.20021964
78. Mihret A, Mamo G, Tafesse M, Hailu A, Parida S. Dendritic Cells Activate and Mature after Infection with Mycobacterium tuberculosis. BMC Res Notes 2011; 4:247; PMID:21777464; http://dx.doi.org/10. 1186/1756-0500-4-247
79. Humphreys IR, Stewart GR, Turner DJ, Patel J, Karamanou D, Snelgrove RJ, et al. A role for dendritic cells in the dissemination of mycobacterial infection. Microbes Infect 2006; 8:1339-46; PMID:16697232; http://dx.doi.org/10.1016/j.micinf.2005.12.023
80. Hedlund S, Persson A, Vujic A, Che KF, Stendahl O, Larsson M. Dendritic cell activation by sensing Mycobacterium tuberculosis-induced apoptotic neutrophils via DC-SIGN. Hum Immunol 2010; 71:535-40; PMID:20219612; http://dx.doi.org/10.1016/j. humimm.2010.02.022
81. Tian T, Woodworth J, Sköld M, Behar SM. In vivo depletion of CD11c+ cells delays the CD4+ T cell response to Mycobacterium tuberculosis and exacerbates the outcome of infection. J Immunol 2005; 175: 3268-72; PMID:16116218
82. Hambleton S, Salem S, Bustamante J, Bigley V, Boisson-Dupuis S, Azevedo J, et al. IRF8 mutations and human dendritic-cell immunodeficiency. N Engl J Med 2011; 365:127-38; PMID:21524210; http://dx. doi.org/10.1056/NEJMoa1100066
83. Sasindran SJ, Torrelles JB. Mycobacterium Tuberculosis Infection and Inflammation: what is Beneficial for the Host and for the Bacterium? Front Microbiol 2011; 2:2; PMID:21687401; http://dx.doi. org/10.3389/fmicb.2011.00002
84. Hanekom WA, Mendillo M, Manca C, Haslett PA, Siddiqui MR, Barry C, 3rd, et al. Mycobacterium tuberculosis inhibits maturation of human monocytederived dendritic cells in vitro. J Infect Dis 2003; 188: 257-66; PMID:12854081; http://dx.doi.org/10.1086/376451
85. Dulphy N, Herrmann JL, Nigou J, Réa D, Boissel N, Puzo G, et al. Intermediate maturation of Mycobacterium tuberculosis LAM-activated human dendritic cells. Cell Microbiol 2007; 9:1412-25; PMID:17253979; http://dx.doi.org/10.1111/j.1462-5822.2006.00881.x
86. Motta A, Schmitz C, Rodrigues L, Ribeiro F, Teixeira C, Detanico T, et al. Mycobacterium tuberculosis heatshock protein 70 impairs maturation of dendritic cells from bone marrow precursors, induces interleukin-10 production and inhibits T-cell proliferation in vitro. Immunology 2007; 121:462-72; PMID:17346283; http://dx.doi.org/10.1111/j.1365-2567.2007.02564.x
87. Wolf AJ, Linas B, Trevejo-Nuñez GJ, Kincaid E, Tamura T, Takatsu K, et al. Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo. J Immunol 2007; 179: 2509-19; PMID:17675513
88. Wolf AJ, Desvignes L, Linas B, Banaiee N, Tamura T, Takatsu K, et al. Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs. J Exp Med 2008; 205:105-15; PMID: 18158321; http://dx.doi.org/10.1084/jem.20071367
89. Balboa L, Romero MM, Yokobori N, Schierloh P, Geffner L, Basile JI, et al. Mycobacterium tuberculosis impairs dendritic cell response by altering CD1b, DCSIGN and MR profile. Immunol Cell Biol 2010; 88: 716-26; PMID:20212510; http://dx.doi.org/10.1038/icb.2010.22
90. Demangel C, Garnier T, Rosenkrands I, Cole ST. Differential effects of prior exposure to environmental mycobacteria on vaccination with Mycobacterium bovis BCG or a recombinant BCG strain expressing RD1 antigens. Infect Immun 2005; 73:2190-6; PMID: 15784562; http://dx.doi.org/10.1128/IAI.73.4.2190-2196.2005
91. Garcia-Romo GS, Pedroza-Gonzalez A, Lambrecht BN, Aguilar-Leon D, Estrada-Garcia I, Hernandez-Pando R, et al. Mycobacterium tuberculosis manipulates pulmonary APCs subverting early immune responses. Immunobiology 2012; In press; PMID:22749983; http://dx.doi.org/10.1016/j.imbio.2012.05.022
92. Dwivedi VP, Bhattacharya D, Chatterjee S, Prasad DV, Chattopadhyay D, Van Kaer L, et al. Mycobacterium tuberculosis directs T helper 2 cell differentiation by inducing interleukin-1beta production in dendritic cells. J Biol Chem 2012; 287:33656-63; PMID:22810226; http://dx.doi.org/10.1074/jbc.M112.375154
93. Trinath J, Maddur MS, Kaveri SV, Balaji KN, Bayry J. Mycobacterium tuberculosis promotes regulatory T-cell expansion via induction of programmed death-1 ligand 1 (PD-L1, CD274) on dendritic cells. J Infect Dis 2012; 205:694-6; PMID:22238465; http://dx.doi.org/10.1093/infdis/jir820
94. Rajashree P, Supriya P, Das SD. Differential migration of human monocyte-derived dendritic cells after infection with prevalent clinical strains of Mycobacterium tuberculosis. Immunobiology 2008; 213:567-75; PMID:18656704; http://dx.doi.org/10.1016/j.imbio. 2008.01.007
95. Mazurek J, Ignatowicz L, Kallenius G, Svenson SB, Pawlowski A, Hamasur B. Divergent effects of mycobacterial cell wall glycolipids on maturation and function of human monocyte-derived dendritic cells. PLoS One 2012; 7:e42515; PMID:22880012; http://dx.doi.org/10.1371/journal.pone.0042515